Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks To Watch: ABEO, COOL, IMGN, SGMO

Published 08/30/2017, 12:20 AM
Updated 07/09/2023, 06:31 AM

Abeona Therapeutics Inc. (NASDAQ:ABEO) had a big pop on Tuesday, popping 1.75, or 18.4%, to 11.25, on 2.8 million shares traded. It had a breakout and a thrust through the July high, and when it crossed the 10.24 area, it closed a dollar higher. At this point, I’m looking for the 14-15 range as the next target, maybe even higher. There’s 20.84 days to cover .

Majesco Entertainment Company (NASDAQ:COOL), a swing trade of ours, was acting really well on Tuesday. We put it out to you at 23.81 on Aug 15, and now it’s trading 6 points higher, reaching as high 29.92 on Tuesday. It was up 1.35, or 4.8%, to 29.46, on 140,001 shares traded. It’s high in June was 30.09. If it gets through that, the targets are 33-4, maybe as high as the high 30’s over the next few weeks going forward. It has 6 days to cover .

Swing trade ImmunoGen, Inc. (NASDAQ:IMGN) was put out on May 16 at 4.88. It reached up to 8.00, pulled back in a 3-wave corrective move, and then broke out on Tuesday, jumping 1.12, or 17%, to 7.58, on 13 million shares traded. That’s the biggest volume since January. Targets are 9 1/2 and 12 1/2. It has 5.5 days to cover .

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is also looking good. This is a swing trade from May 11 at 6.68. On Tuesday, it was up 1.30, or 11.3%, to 12.80, on 3.3 million shares traded, reaching a high of 12.90. My current targets are 11 1/2 and 13. My target going forward is 17. It had 3.6 days to cover .

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On the long side, stocks included Abeona Therapeutics Inc. (ABEO), Agnico Eagle Mines Limited (NYSE:AEM), Majesco Entertainment Company (COOL), Corcept Therapeutics Incorporated (NASDAQ:CORT), Catalent, Inc. (NYSE:CTLT), Fate Therapeutics, Inc. (NASDAQ:FATE), Amicus Therapeutics, Inc. (NASDAQ:FOLD), First Solar, Inc. (NASDAQ:FSLR), Health Insurance Innovations, Inc. (NASDAQ:HIIQ), ImmunoGen, Inc. (IMGN), Juno Therapeutics Inc. (NASDAQ:JUNO), KEMET Corporation (NYSE:KEM), Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), Movado Group, Inc. (NYSE:MOV), Puma Biotechnology, Inc. (NASDAQ:PBYI), Sangamo Therapeutics, Inc. (NASDAQ:SGMO), Swift Transportation Company (NYSE:SWFT), Vericel Corporation (NASDAQ:VCEL), and YRC Worldwide Inc. (NASDAQ:YRCW).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.